PropertyValue
?:abstract
  • The importance of venous thromboembolism (VTE) as a major complication in patients with severe corona virus disease 2019 (COVID-19) is becoming increasingly evident In this review, we describe the proposed pathophysiology of the prothrombotic coagulation changes observed in patients with COVID-19 Further, based on a review of the currently available evidence on VTE prevalence in patients with COVID-19, we present and discuss the recommendations from the Danish Society of Thrombosis and Haemostasis on the use of thromboprophylaxis in patients with COVID-19
is ?:annotates of
?:creator
?:journal
  • Ugeskrift_for_laeger
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • [Isoflavones have therapeutic efficacy inoestrogen deficiency]
?:type
?:who_covidence_id
  • #592853
?:year
  • 2020

Metadata

Anon_0  
expand all